Key Insights

Highlights

Success Rate

91% trial completion (above average)

Published Results

21 trials with published results (26%)

Research Maturity

53 completed trials (65% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.1%

5 terminated out of 82 trials

Success Rate

91.4%

+4.8% vs benchmark

Late-Stage Pipeline

15%

12 trials in Phase 3/4

Results Transparency

40%

21 of 53 completed with results

Key Signals

21 with results91% success

Data Visualizations

Phase Distribution

61Total
Not Applicable (26)
P 1 (15)
P 2 (8)
P 3 (5)
P 4 (7)

Trial Status

Completed53
Recruiting10
Unknown8
Terminated5
Not Yet Recruiting4
Active Not Recruiting1

Trial Success Rate

91.4%

Benchmark: 86.6%

Based on 53 completed trials

Clinical Trials (82)

Showing 20 of 20 trials
NCT07044297Phase 3RecruitingPrimary

A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

NCT07600775Phase 1Not Yet RecruitingPrimary

A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuberculosis Infection (MK-8527-019)

NCT07466836Not ApplicableTerminatedPrimary

The Effects of Chiropractic Care on Inflammation and Quality of Life in People Living With HIV

NCT05657106Not ApplicableActive Not Recruiting

Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk

NCT05664802Not ApplicableCompletedPrimary

e-HERO: Ending the HIV Epidemic in Rural Oklahoma

NCT07071623Phase 3RecruitingPrimary

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

NCT07707778Phase 4Enrolling By InvitationPrimary

Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV

NCT06880705Not ApplicableRecruiting

The Trans-Led Care Study

NCT07553052Not ApplicableCompletedPrimary

Vitamin D3 Supplementation in Patients With HIV: Effects on Interleukin-6 Levels and CD4 Counts

NCT07089966Not ApplicableRecruitingPrimary

HIV Testing Counselor-led Care to Catalyze Integration of PrEP Delivery in Family Planning Clinics

NCT07520188Not Yet RecruitingPrimary

C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the United States

NCT07581600Not ApplicableNot Yet RecruitingPrimary

ComBaCaL HIV Prevention TwiCs

NCT07576842Not ApplicableNot Yet Recruiting

Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV

NCT06598397Phase 4RecruitingPrimary

Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care

NCT05968573Not ApplicableRecruitingPrimary

Persuasive Health Communication Intervention for HIV/HCV

NCT07418385RecruitingPrimary

Voluntary HIV Screening in the General Population in France

NCT05423418Phase 1CompletedPrimary

Safety, Tolerability, and Immunogenicity of ALFQ in a HIV Vaccine Containing A244 and B.65321 in Healthy Adults

NCT06883097Not ApplicableRecruiting

Quitting Matters Human Immunodeficiency Virus Hybrid Trial

NCT07030920Phase 2RecruitingPrimary

Reducing Systemic Inflammation in People on Antiretroviral Therapy

NCT02990858Phase 2TerminatedPrimary

An Extension Protocol for Subjects Who Successfully Completed PRO140_CD02 or PRO140_CD02_Open Label Study

Scroll to load more

Research Network

Activity Timeline